- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 471/14 - Ortho-condensed systems
Patent holdings for IPC class C07D 471/14
Total number of patents in this class: 2103
10-year publication summary
|
136
|
107
|
144
|
159
|
162
|
168
|
200
|
180
|
216
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5849 |
67 |
| Intra-Cellular Therapies, Inc. | 393 |
54 |
| Incyte Corporation | 961 |
48 |
| Shionogi & Co., Ltd. | 890 |
40 |
| Bristol-myers Squibb Company | 4886 |
39 |
| Novartis AG | 11297 |
33 |
| Genentech, Inc. | 3864 |
27 |
| King Faisal University | 821 |
27 |
| Janssen Pharmaceutica N.V. | 3625 |
26 |
| Gilead Sciences, Inc. | 1949 |
25 |
| Merck Sharp & Dohme LLC | 3742 |
22 |
| Janssen Sciences Ireland Unlimited Company | 434 |
21 |
| Vertex Pharmaceuticals Incorporated | 1570 |
20 |
| F. Hoffmann-La Roche AG | 7942 |
17 |
| Dana-Farber Cancer Institute, Inc. | 2531 |
15 |
| Sudo Biosciences Limited | 22 |
15 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 803 |
14 |
| Amgen Inc. | 3894 |
13 |
| AC Immune S.A. | 243 |
13 |
| Incyte Holdings Corporation | 652 |
13 |
| Other owners | 1554 |